| Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing A Ståhlberg, PM Krzyzanowski, M Egyud, S Filges, L Stein, TE Godfrey Nature protocols 12 (4), 664-682, 2017 | 130 | 2017 |
| The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, ... Nature communications 12 (1), 5155, 2021 | 116 | 2021 |
| Considerations and quality controls when analyzing cell-free tumor DNA G Johansson, D Andersson, S Filges, J Li, A Muth, TE Godfrey, ... Biomolecular Detection and Quantification 17 (March 2019), 100078, 2019 | 101 | 2019 |
| Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature NJ Fredriksson, K Elliott, S Filges, J Van den Eynden, A Ståhlberg, ... PLoS genetics 13 (5), e1006773, 2017 | 78 | 2017 |
| Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers K Elliott, M Boström, S Filges, M Lindberg, J Van den Eynden, A Ståhlberg, ... PLoS genetics 14 (12), e1007849, 2018 | 76 | 2018 |
| Impact of polymerase fidelity on background error rates in next-generation sequencing with unique molecular identifiers/barcodes S Filges, E Yamada, A Ståhlberg, TE Godfrey Scientific reports 9 (1), 3503, 2019 | 64 | 2019 |
| Detection of circulating tumor DNA in plasma: a potential biomarker for esophageal adenocarcinoma M Egyud, M Tejani, A Pennathur, J Luketich, P Sridhar, E Yamada, ... The Annals of thoracic surgery 108 (2), 343-349, 2019 | 51 | 2019 |
| Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer M Egyud, P Sridhar, A Devaiah, E Yamada, S Saunders, A Ståhlberg, ... Head & neck 41 (5), 1351-1358, 2019 | 37 | 2019 |
| Multilaboratory assessment of a new reference material for quality assurance of cell-free tumor DNA measurements HJ He, EV Stein, Y Konigshofer, T Forbes, FL Tomson, R Garlick, ... The Journal of Molecular Diagnostics 21 (4), 658-676, 2019 | 20 | 2019 |
| Digital quantification of chemical oligonucleotide synthesis errors S Filges, P Mouhanna, A Ståhlberg Clinical Chemistry 67 (10), 1384-1394, 2021 | 14 | 2021 |
| Extracellular vesicle DNA from human melanoma tissues contains cancer-specific mutations R Crescitelli, S Filges, N Karimi, O Urzì, T Alonso-Agudo, A Ståhlberg, ... Frontiers in Cell and Developmental Biology 10, 1028854, 2022 | 10 | 2022 |
| Modelling and analysis of a gene-regulatory feed-forward loop with basal expression of the second regulator L Roselius, D Langemann, J Müller, BA Hense, S Filges, D Jahn, ... Journal of theoretical biology 363, 290-299, 2014 | 9 | 2014 |
| UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers T Österlund, S Filges, G Johansson, A Ståhlberg Clinical Chemistry, 2022 | 8 | 2022 |
| Response to BRAF/MEK inhibition in A598_T599insV BRAF mutated melanoma S Bjursten, C Vannas, S Filges, F Puls, A Pandita, H Fagman, A Ståhlberg, ... Case Reports in Oncology 12 (3), 872-879, 2020 | 8 | 2020 |
| Dynamic ctDNA evaluation of a patient with BRAFV600E metastatic melanoma demonstrates the utility of ctDNA for disease monitoring and tumor clonality analysis C Vannas, S Bjursten, S Filges, H Fagman, A Ståhlberg, M Levin Acta Oncologica 59 (11), 1388-1392, 2020 | 3 | 2020 |
| Tissue specificity of oncogenic BRAF targeted to lung and thyroid through a shared lineage factor E Schoultz, S Liang, T Carlsson, S Filges, A Ståhlberg, H Fagman, C Wiel, ... Iscience 26 (7), 2023 | 1 | 2023 |
| Deciphering the role of FUS:: DDIT3 expression and tumor microenvironment in myxoid liposarcoma development P Ranji, E Jonasson, L Andersson, S Filges, M Luna Santamaría, ... Journal of Translational Medicine 22 (1), 389, 2024 | | 2024 |
| Next generation molecular diagnostics using ultrasensitive sequencing S Filges | | 2022 |
